Bourgeon Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-353,832
Closed -$6.77M 127
2024
Q3
$6.77M Buy
353,832
+141,555
+67% +$2.93M 1.3% 32
2024
Q2
$4.39M Buy
212,277
+824
+0.4% +$16.4K 0.86% 41
2024
Q1
$3.98M Buy
211,453
+144,232
+215% +$2.48M 0.78% 44
2023
Q4
$969K Sell
67,221
-233,481
-78% -$3.18M 0.21% 66
2023
Q3
$5.22M Sell
300,702
-536
-0.2% -$11.2K 1.23% 35
2023
Q2
$6.27M Sell
301,238
-2,570
-0.8% -$55.9K 1.46% 28
2023
Q1
$7.15M Buy
303,808
+11,857
+4% +$318K 1.7% 24
2022
Q4
$8.15M Sell
291,951
-21,372
-7% -$546K 2% 21
2022
Q3
$7.33M Buy
313,323
+7,732
+3% +$233K 2.02% 24
2022
Q2
$10.3M Buy
305,591
+5,482
+2% +$192K 2.73% 12
2022
Q1
$10.5M Buy
300,109
+12,027
+4% +$411K 2.37% 18
2021
Q4
$8.77M Buy
288,082
+71,677
+33% +$2.33M 1.81% 20
2021
Q3
$7.1M Sell
216,405
-3,692
-2% -$118K 1.52% 25
2021
Q2
$6.66M Buy
+220,097
New +$7.25M 1.43% 29

Other funds holding OGN

Bourgeon Capital Management's OGN Position: Q4 2024 in Review

Bourgeon Capital Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 353,832 shares — an estimated $6.77M sold.

Bourgeon Capital Management first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $10.5M in Q1 2022. 739 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Bourgeon Capital Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Bourgeon Capital Management sold 353,832 Organon & Co shares in Q4 2024, an estimated $6.77M.
  • Bourgeon Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Bourgeon Capital Management's Organon & Co position peaked at $10.5M in Q1 2022.
  • 739 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Bourgeon Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.